70 related articles for article (PubMed ID: 17557133)
1. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes.
Spatz SJ; Silva RF
Arch Virol; 2007; 152(9):1665-78. PubMed ID: 17557133
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.
Spatz SJ; Silva RF
Virus Genes; 2007 Aug; 35(1):41-53. PubMed ID: 16964553
[TBL] [Abstract][Full Text] [Related]
3. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
Spatz SJ; Rue CA
Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
[TBL] [Abstract][Full Text] [Related]
4. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2.
Spatz SJ
Virus Res; 2010 May; 149(2):135-42. PubMed ID: 20109506
[TBL] [Abstract][Full Text] [Related]
6. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
[TBL] [Abstract][Full Text] [Related]
7. Genetic evolution of Gallid herpesvirus 2 isolated in China.
Lv H; Zhang Y; Sun G; Bao K; Gao Y; Qi X; Cui H; Wang Y; Li K; Gao L; Pan Q; Wang X; Liu C
Infect Genet Evol; 2017 Jul; 51():263-274. PubMed ID: 27112385
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.
Zhang YP; Bao KY; Sun GR; Lv HC; Cui HY; Gao YL; Wang XM; Liu CJ
Virus Genes; 2017 Jun; 53(3):386-391. PubMed ID: 28194622
[TBL] [Abstract][Full Text] [Related]
9. Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.
Cheng Y; Cong F; Zhang YP; Li ZJ; Xu NN; Hou GY; Liu CJ
Virus Genes; 2012 Aug; 45(1):56-62. PubMed ID: 22476905
[TBL] [Abstract][Full Text] [Related]
10. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
[TBL] [Abstract][Full Text] [Related]
11. Variations in the H/ACA box sequence of viral telomerase RNA of isolates of CVI988 Rispens vaccine.
Debba-Pavard M; Le Galludec H; Dambrine G; Rasschaert D
Arch Virol; 2008; 153(8):1563-8. PubMed ID: 18594940
[TBL] [Abstract][Full Text] [Related]
12. Vaccine and oncogenic strains of gallid herpesvirus 2 contain specific subtype variations in the 5' region of the latency-associated transcript that evolve in vitro and in vivo.
Labaille J; Lion A; Boissel E; Trapp S; Nair V; Rasschaert D; Dambrine G
Arch Virol; 2015 Jan; 160(1):161-71. PubMed ID: 25298182
[TBL] [Abstract][Full Text] [Related]
13. Complete genome sequence of virulent duck enteritis virus (DEV) strain 2085 and comparison with genome sequences of virulent and attenuated DEV strains.
Wang J; Höper D; Beer M; Osterrieder N
Virus Res; 2011 Sep; 160(1-2):316-25. PubMed ID: 21802458
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the genomic termini and cleavage/packaging signals of gallid herpesvirus type 2.
Volkening JD; Spatz SJ
Avian Dis; 2013 Jun; 57(2 Suppl):401-8. PubMed ID: 23901753
[TBL] [Abstract][Full Text] [Related]
16. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.
Spatz SJ; Rue C; Schumacher D; Osterrieder N
Virus Genes; 2008 Aug; 37(1):69-80. PubMed ID: 18516669
[TBL] [Abstract][Full Text] [Related]
17. Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.
Spatz SJ; Volkening JD; Gimeno IM; Heidari M; Witter RL
Virus Genes; 2012 Dec; 45(3):526-36. PubMed ID: 22923089
[TBL] [Abstract][Full Text] [Related]
18. Phylogeny and recombination history of gallid herpesvirus 2 (Marek's disease virus) genomes.
Hughes AL; Rivailler P
Virus Res; 2007 Dec; 130(1-2):28-33. PubMed ID: 17566585
[TBL] [Abstract][Full Text] [Related]
19. Genotypic characterization of two bacterial artificial chromosome clones derived from a single DNA source of the very virulent gallid herpesvirus-2 strain C12/130.
Spatz SJ; Smith LP; Baigent SJ; Petherbridge L; Nair V
J Gen Virol; 2011 Jul; 92(Pt 7):1500-1507. PubMed ID: 21450941
[TBL] [Abstract][Full Text] [Related]
20. Stability of Marek's disease virus 132-bp repeats during serial in vitro passages.
Niikura M; Dodgson JB; Cheng HH
Arch Virol; 2006 Jul; 151(7):1431-8. PubMed ID: 16489507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
